Siemens Healthineers Biograph PET/CT scanners

Are you truly ready for what's next in PET/CT? What you should know to prepare

Understanding PET/CT's expansion

If your work is impacted by PET/CT (or will be in the future), you should be aware of the predicted rapid growth in this imaging exam, which will be fueled by:

Prostate imaging and theranostics

PET oncology scans for prostate cancer increased 46% year-over-year.1

Cardiac PET/CT scans

Adoption of cardiac PET

Cardiac PET myocardial perfusion imaging has been gaining momentum, primarily due to the imaging's superior characteristics in comparison with other noninvasive modalities.2

syngo.via PET/CT scans

New Alzheimer's therapies

Alzheimer's disease affects more than six million Americans and ranks as the sixth leading cause of death among American adults.3 New therapies may fuel growth in neurological PET/CT. 

More Information

1    IMV data on file
2
https://link.springer.com/article/10.1007/s12350-019-01986-4 
3
 Alzheimer's Facts and Figures Report | Alzheimer's Association 
Video courtesy of Inselspital, Bern University Hospital, Bern, Switzerland.
Image courtesy of Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
Image courtesy of University of Tennessee Medical Center, Knoxville, Tennessee, USA.
Biograph Vision Quadra™ is not commercially available in all countries. Future availability cannot be guaranteed.
Subscription Button Icon

Subscribe to news from Siemens Healthineers USA

Be the first to know about our events, training, and news